Last reviewed · How we verify
Single-Dose Food In Vivo Bioequivalence Study of Cetirizine HCl Tablets (10 mg; Mylan) and Zyrtec® (10 mg; Pfizer) in Healthy Volunteers
The objective of this study was to investigate the bioequivalence of Mylan's cetirizine HCl tablets to Pfizer's Zyrtec® tablets following a single, oral 10 mg (1 x 10 mg) dose administered under fed conditions.
Details
| Lead sponsor | Mylan Pharmaceuticals Inc |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 18 |
| Start date | 2002-11 |
| Completion | 2002-12 |
Conditions
- Healthy
Interventions
- Cetirizine HCl Tablets 10 mg
- Zyrtec® 10 mg
Primary outcomes
- Bioequivalence — within 30 days
Countries
United States